Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • LUNR vs GSK✓SelectedUSD · GSKLUNR vs GSK performance historyLatest closeAs of-9.77%11/16
Stock and ETF performance explorer

LUNR vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+21.6%
GSK return
+47.4%
Excess return
-25.8%
Maximum drawdown
-97.4%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-9.8%-0.1%-9.7%-9.8%
7D-2.6%-1.3%-1.3%-2.9%
30D+8.8%+2.7%+6.1%+9.8%
3M-38.3%+2.7%-41.0%-37.6%
6M-65.4%+3.3%-68.7%-64.8%
YTD-27.7%+6.5%-34.2%-25.4%
1Y+23.1%+10.7%+12.4%+28.3%
3Y+294.9%+64.4%+230.6%+383.5%
All+21.6%+47.4%-25.8%+51.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling